<DOC>
	<DOCNO>NCT01555749</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial investigate pharmacokinetics ( trial drug distribute body ) NNC172-2021 administer subcutaneously , two different dose level , healthy Japanese subject .</brief_summary>
	<brief_title>Investigation Pharmacokinetics NNC172-2021 , Two Different Dose Levels , Healthy Japanese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>Healthy male Japanese subject define : Subjects born Japan , time reside outside Japan exceed 5 year , parent 4 grandparent Japanese descent Body weight 50 100 kg , inclusive Body mass index ( BMI ) 18.0 30.0 kg/m^2 , inclusive Male subject sexually active surgically sterilise , whose partner , unwilling use two different form effective contraception , one barrier method contraception ( e.g . condom spermicidal foam/gel/film/cream ) duration trial 3 month follow last dose trial medication Planned surgery 30 day prior trial product administration and/or entire trial period Known hepatic dysfunction last 12 month prior screen ( Visit 1 ) Positive urine test drug abuse Active hepatitis B and/or hepatitis C infection Positive human immunodeficiency virus ( HIV ) Subjects clinical sign thromboembolic event , consider high risk thromboembolic event subject know first degree family history thromboembolism Participation trial investigating product involve blood sample within last 30 day prior screen Use nonsteroidal antiinflammatory drug ( NSAIDs ) acetylsalicylic acid ( ASA ) , ibuprofen cyclooxygenase2 ( COX2 ) specific inhibitor within 2 week prior trial product administration ( Visit 2 ) Positive alcohol test screening ( Visit 1 ) and/or history alcohol drug abuse within last 12 month prior screen ( Visit 1 ) Smokers ; define tobacco user smoke 5 cigarette per day correspond amount tobacco consumption Blood donation within last 3 month prior screen and/or entire trial period Strenuous exercise ( judge trial physician ) within last 4 day prior screen ( Visit 1 )</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>